Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
Osteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advance...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/full |
_version_ | 1818606593444413440 |
---|---|
author | Chunfeng Xu Mingjie Wang Wei Guo Wei Sun Wei Sun Yuelian Liu |
author_facet | Chunfeng Xu Mingjie Wang Wei Guo Wei Sun Wei Sun Yuelian Liu |
author_sort | Chunfeng Xu |
collection | DOAJ |
description | Osteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advanced treatments (e.g. chemotherapy, immunotherapy, radiotherapy) are coming up, the 5-year survival rate for osteosarcoma with metastases is still dismal. In line with this, the more potent treatments for osteosarcoma are in high demand. Curcumin, a perennial herb, has been reportedly applied in the therapy of various types of tumors via different mechanisms. In vitro, it has also been reported that curcumin can inhibit the proliferation of osteosarcoma cell lines and can be used to repair bone defects. This seems curcumin is a promising candidate in osteosarcoma treatment. However, due to its congenital property like hydrophobicity, and low bioavailability, affecting its anticancer effect, clinical applications of curcumin are highly limited. To enhance its performance in cancer therapies, some synergist approaches with curcumin have emerged. The present review presents some prospective ones (i.e. combinations with immunotherapy, chemotherapeutics, bone tissue engineering, and biomaterials) applied in osteosarcoma treatment. Additionally, with the advancements of photodynamic therapy in cancer therapy, this review also prospects the combination of curcumin with photodynamic therapy in osteosarcoma treatment. |
first_indexed | 2024-12-16T14:13:19Z |
format | Article |
id | doaj.art-691ecbec320949d880c07593a652c8e6 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-16T14:13:19Z |
publishDate | 2021-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-691ecbec320949d880c07593a652c8e62022-12-21T22:28:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.672490672490Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic TherapyChunfeng Xu0Mingjie Wang1Wei Guo2Wei Sun3Wei Sun4Yuelian Liu5Section of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsSection of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsDepartment of Oral–Maxillofacial and Head–Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Mechanical Engineering, Drexel University, Philadelphia, PA, United StatesDepartment of Mechanical Engineering, Tsinghua University, Beijing, ChinaSection of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsOsteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advanced treatments (e.g. chemotherapy, immunotherapy, radiotherapy) are coming up, the 5-year survival rate for osteosarcoma with metastases is still dismal. In line with this, the more potent treatments for osteosarcoma are in high demand. Curcumin, a perennial herb, has been reportedly applied in the therapy of various types of tumors via different mechanisms. In vitro, it has also been reported that curcumin can inhibit the proliferation of osteosarcoma cell lines and can be used to repair bone defects. This seems curcumin is a promising candidate in osteosarcoma treatment. However, due to its congenital property like hydrophobicity, and low bioavailability, affecting its anticancer effect, clinical applications of curcumin are highly limited. To enhance its performance in cancer therapies, some synergist approaches with curcumin have emerged. The present review presents some prospective ones (i.e. combinations with immunotherapy, chemotherapeutics, bone tissue engineering, and biomaterials) applied in osteosarcoma treatment. Additionally, with the advancements of photodynamic therapy in cancer therapy, this review also prospects the combination of curcumin with photodynamic therapy in osteosarcoma treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/fullosteosarcomacurcuminimmunotherapychemotherapybone tissue engineeringbiomaterials |
spellingShingle | Chunfeng Xu Mingjie Wang Wei Guo Wei Sun Wei Sun Yuelian Liu Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy Frontiers in Oncology osteosarcoma curcumin immunotherapy chemotherapy bone tissue engineering biomaterials |
title | Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy |
title_full | Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy |
title_fullStr | Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy |
title_full_unstemmed | Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy |
title_short | Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy |
title_sort | curcumin in osteosarcoma therapy combining with immunotherapy chemotherapeutics bone tissue engineering materials and potential synergism with photodynamic therapy |
topic | osteosarcoma curcumin immunotherapy chemotherapy bone tissue engineering biomaterials |
url | https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/full |
work_keys_str_mv | AT chunfengxu curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy AT mingjiewang curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy AT weiguo curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy AT weisun curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy AT weisun curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy AT yuelianliu curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy |